REXIS Biotech And Smokiez Team Up To Introduce Hemp Delta 9 Beverages Across The US

Rexis Biotech Inc., a leading innovator in hydrophobic molecule delivery systems, has announced an exciting expansion of its partnership with Smokiez, a prominent player in the regulated cannabis market. This collaboration heralds the national launch of Smokiez' high-quality, hemp-derived beverages, utilizing Rexis' advanced Hydro Fiber technology. The partnership aims to leverage Rexis' extensive distribution network, enabling immediate access to these innovative beverages across thousands of retail stores nationwide.

Chuck Wright, CEO of Smokiez, expressed enthusiasm about the partnership, highlighting the superior quality of Rexis’ Hydro Fiber technology. This technology has enabled Smokiez to produce a beverage that meets the high standards of flavor and experience that their clients expect. Keith Bushfield, CEO of Rexis Biotech Inc., also shared his excitement, noting Smokiez's strong reputation in the edibles market and expressing confidence in bringing this top-quality brand to mainstream consumers across the country.

This strategic alliance marks a significant milestone for Rexis Biotech, emphasizing its commitment to innovation and quality in the cannabis beverage industry. It sets new standards for consumer experiences nationwide, promising to introduce a new era of cannabis-infused beverages that combine quality, taste, and accessibility.

Founded in 2022, Rexis Biotech Inc. stands at the forefront of developing Hydrophobic Molecule Delivery systems. The company specializes in the innovation, production, and formulation of water-based ingredients for the Pharmaceutical and Consumer Packaged Goods industry. With a focus on building a robust portfolio of proprietary intellectual property, Rexis aims to support strong sales models with pharmaceutical licensees, consumer packaged goods manufacturers, and clinical research teams. Currently engaged in raising capital via WeFunder to support its growth trajectory, Rexis is poised for significant advancements in its field.

For further information about Rexis Biotech Inc. and its pioneering technologies, please visit their official website.

Note: This news release contains forward-looking statements subject to risks and uncertainties. All statements made are based on current expectations and involve various risks and uncertainties that could cause actual results to differ materially from those expressed. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.